Indivior (LON:INDV) Stock Passes Above 50-Day Moving Average – Should You Sell?

Indivior PLC (LON:INDV)’s stock price passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 1,238 and traded as high as GBX 1,264. Indivior shares last traded at GBX 1,238, with a volume of 8,457,898 shares traded.

Indivior Stock Performance

The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06. The stock’s 50 day moving average price is GBX 1,238 and its 200 day moving average price is GBX 1,196.56. The company has a market cap of £1.93 billion, a price-to-earnings ratio of -1,026.48, a P/E/G ratio of -5.57 and a beta of 0.19.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder.